Limited time75% off all plans
Get the app

Negative feedback mechanisms

Negative feedback mechanisms

Negative feedback mechanisms

On this page

RAAS Cascade - The Pressure Crew

RAAS Cascade with Angiotensin II Negative Feedback

The RAAS is a hormonal cascade that regulates blood pressure and fluid balance. It is initiated by decreased renal perfusion or low sodium delivery to the distal tubule.

  • Trigger: ↓ Blood pressure or ↓ Na⁺ detected by macula densa.
  • Release: Juxtaglomerular (JG) cells in the kidney secrete Renin.

⭐ The primary site of Angiotensin-Converting Enzyme (ACE) activity is the capillary endothelium of the lungs.

  • Angiotensin II is the main effector, causing potent vasoconstriction and stimulating Aldosterone secretion.
  • Aldosterone acts on the distal nephron to increase Na⁺ and water reabsorption, raising blood volume.

Negative Feedback - Pumping the Brakes

RAAS pathway with negative feedback and regulation

Multiple overlapping mechanisms regulate the RAAS to prevent over-activation.

  • Short-Loop Feedback: Angiotensin II directly inhibits renin secretion from the juxtaglomerular (JG) cells of the kidney. This is a direct, local inhibitory effect.
  • Long-Loop Feedback: Systemic changes triggered by RAAS activation ultimately suppress it.
    • ↑ Blood Pressure: Increased systemic arterial pressure, sensed by renal afferent arterioles, directly decreases renin release.
    • ↑ Na+ Delivery: Aldosterone-driven Na+ retention increases Na+ load at the macula densa, which signals JG cells to ↓ renin (Tubuloglomerular feedback).

⭐ Atrial Natriuretic Peptide (ANP), released from atrial myocytes in response to stretch, is the main physiological antagonist of the RAAS.

Clinical Tie-ins - Meds & Mayhem

  • Pharmacological Intervention:

    • ACE Inhibitors (-prils): Inhibit ACE, ↓ Ang II & aldosterone. Used for hypertension & heart failure.
      • 📌 ACE inhibitors cause Cough, Angioedema, & Teratogenicity (Captopril's CAT).
    • ARBs (-sartans): Selectively block AT1 receptors, preventing Ang II effects. No impact on bradykinin (no cough).
    • Aldosterone Antagonists (Spironolactone): Block mineralocorticoid receptors. Useful for Conn's syndrome & advanced heart failure.
    • ⚠️ All can cause hyperkalemia, a key side effect to monitor.
  • Pathological States:

    • Renal Artery Stenosis: Decreased renal perfusion chronically activates RAAS, leading to severe secondary hypertension.
    • Conn's Syndrome: Primary hyperaldosteronism causes hypertension, hypokalemia, and metabolic alkalosis.

⭐ The characteristic dry cough associated with ACE inhibitors is due to the accumulation of bradykinin, which is normally degraded by ACE.

High‑Yield Points - ⚡ Biggest Takeaways

  • High blood pressure is the primary long-loop feedback signal, suppressing renin release from the juxtaglomerular apparatus.
  • Angiotensin II exerts direct short-loop negative feedback on JG cells to ↓ renin secretion.
  • Aldosterone-mediated ↑ in Na+ and water retention raises blood volume, indirectly inhibiting renin.
  • Atrial Natriuretic Peptide (ANP), released in response to atrial stretch, directly inhibits both renin and aldosterone secretion.
  • ACE inhibitors & ARBs interrupt the feedback loop, causing a compensatory ↑ in plasma renin activity.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE